PMC:7696151 / 64858-65197 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1898","span":{"begin":241,"end":244},"obj":"Chemical"},{"id":"1917","span":{"begin":120,"end":132},"obj":"Disease"},{"id":"1918","span":{"begin":202,"end":224},"obj":"Disease"}],"attributes":[{"id":"A1898","pred":"tao:has_database_id","subj":"1898","obj":"MESH:D006886"},{"id":"A1917","pred":"tao:has_database_id","subj":"1917","obj":"MESH:D007249"},{"id":"A1918","pred":"tao:has_database_id","subj":"1918","obj":"MESH:D006976"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" tract, where alterations in the immune homeostasis of the intestinal mucosa had a positive impact on the disease [74]. Inflammation, together with alterations in the immune system, are at the basis of pulmonary hypertension. The ability of HCQ to interfere with the production of pro-inflammatory cytokines from monocytes and lymphocytes "}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T117","span":{"begin":212,"end":224},"obj":"Phenotype"}],"attributes":[{"id":"A117","pred":"hp_id","subj":"T117","obj":"http://purl.obolibrary.org/obo/HP_0000822"}],"text":" tract, where alterations in the immune homeostasis of the intestinal mucosa had a positive impact on the disease [74]. Inflammation, together with alterations in the immune system, are at the basis of pulmonary hypertension. The ability of HCQ to interfere with the production of pro-inflammatory cytokines from monocytes and lymphocytes "}

{"project":"LitCovid-sentences","denotations":[{"id":"T416","span":{"begin":120,"end":225},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" tract, where alterations in the immune homeostasis of the intestinal mucosa had a positive impact on the disease [74]. Inflammation, together with alterations in the immune system, are at the basis of pulmonary hypertension. The ability of HCQ to interfere with the production of pro-inflammatory cytokines from monocytes and lymphocytes "}